C21 Investments Inc.

CXXI

CA12675Q1019

Pharmaceuticals

Market Closed - Canadian Securities Exchange Other stock markets 03:59:59 2024-09-19 pm EDT			5-day change	1st Jan Change
0.3150 ^CAD	0.00%		+8.62%	-1.56%

Aug. 16	C21 Investments Reports Q1 Net Loss, no Comparable Figures Available	MT
Aug. 16	C21 Investments Inc. Reports Earnings Results for the First Quarter Ended June 30, 2024	CI

C21 Investments Inc. Reports Earnings Results for the Two Months Ended March 31, 2024

August 01, 2024 at 07:53 pm EDT

C21 Investments Inc. reported earnings results for the two months ended March 31, 2024. For the two months, the company reported sales was USD 4.46 million. Net loss was USD 0.074404 million.

Latest news about C21 Investments Inc.

C21 Investments Reports Q1 Net Loss, no Comparable Figures Available	Aug. 16	MT
C21 Investments Inc. Reports Earnings Results for the First Quarter Ended June 30, 2024	Aug. 16	CI
Earnings Flash (CXXIF) C21 INVESTMENTS Reports Fiscal Q1 Loss $-0.01	Aug. 16	MT
C21 Investments Inc. Reports Earnings Results for the Two Months Ended March 31, 2024	Aug. 01	CI
C21 Investments Inc. Closes Acquisition of Cannabis Dispensary in Reno, Nevada	Jun. 10	CI
C21 Investments Closes US$3.5-Million Purchase of Cannabis Dispensary in Reno, Nevada	Jun. 10	MT
C21 Investments Inc. Has Determines to Change Its Year-End from January 31 to March 31	Jun. 04	CI
C21 Investments Inc. Reports Earnings Results for the Fourth Quarter Ended January 31, 2024	May. 08	CI
C21 Investments Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended January 31, 2024	May. 08	CI
C21 Investments Inc. announced that it has received CAD 4 million in funding	May. 05	CI
C21 Investments Inc. announced that it expects to receive CAD 4 million in funding	Mar. 14	CI
C21 Investments Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended October 31, 2023	Dec. 14	CI
C21 Investments Swings to Loss in Fiscal Q2; Down 5.7%	23-09-21	MT
C21 Investments Swings to Loss in Fiscal Q2	23-09-21	MT
C21 Investments Inc. Reports Earnings Results for the Second Quarter and Six Months Ended July 31, 2023	23-09-21	CI
C21 Investments Inc. Announces Appointment of Aron Swan as Chief Operating Officer	23-09-07	CI
C21 Investments Swings to Loss in Fiscal Q1, Revenue Rises	23-06-29	MT
C21 Investments Inc. Reports Earnings Results for the First Quarter Ended April 30, 2023	23-06-29	CI
C21 Investments Inc. Reports Earnings Results for the Full Year Ended January 31, 2023	23-06-13	CI
C21 Investments' Fiscal Q4 Loss Widens, Revenue Falls; Completes Full Repayment of $30 Million Senior Secured Note	23-06-02	MT
C21 Investments' Shares Rally After Senior Secured Note Fully Repaid	23-06-02	DJ
C21 Investments' Fiscal Q4 Loss Widens, Revenue Falls; Completes Full Repayment of $30 Million Senior Secured Note	23-06-02	MT
C21 Investments Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended October 31, 2022	22-12-15	CI
C21 Investments Q2 EPS US$0.02 Vs US$0.03 Year Ago; Revenue Falls	22-09-22	MT
C21 Investments Inc. Reports Earnings Results for the Second Quarter and Six Months Ended July 31, 2022	22-09-21	CI

C21 Investments Inc. is a Canada-based vertically integrated cannabis company. The Company cultivates, processes, and distributes cannabis and hemp-derived consumer products in the United States. The Company is focused on value creation through the disciplined acquisition and integration of core retail, manufacturing, and distribution assets in strategic markets, leveraging industry- retail revenues with multi-market branded consumer packaged goods. The Company holds licenses in Nevada spanning the entire cannabis supply chain. The Company owns Silver State Relief and Silver State Cultivation in Nevada, including legacy Oregon brands Phantom Farms, Hood Oil and Eco Firma Farms. These brands produce and distribute a broad range of tetrahydrocannabinol (THC) and cannabidiol (CBD) products from cannabis flowers, pre-rolls, cannabis oil, vaporizer cartridges and edibles. The Company operates in the state of Nevada.

Employees

116

Sector

Pharmaceuticals

Calendar

2024-09-24 - Q2 2025 Earnings Release (Projected)

More about the company